Organigram Global Inc. · TSX:OGI

Organigram Global — Investor Presentation (November 2014)

21 slides from Organigram Global's investor presentation, November 2014

  1. Slide 1: Investor Presentation

    November 2014 Investor Presentation www.organigram.ca ORGANIGRAM has been approved for licensing by Health Canada to become a commercial producer of medical marijuana for the Canadian market.

  2. Slide 2: Disclaimers and Cautionary Statements

    Disclaimers and Cautionary Statements The informa-on contained in this presenta-on is provided by OrganiGram (“OGI”) for informa-onal purposes only and does not cons-tute an offer to issue or arrange to issue, or the solicita-on of an offer to issue, securi-es of OGI or other financial products. The in

  3. Slide 3: Mission

    ORGANIGRAM’s mission is to become a leading producer of condi-on specific medical marijuana in Canada. By combining advanced technologies and proven methods, we assure a high quality, secure and regulated source of organically grown medical marijuana for pa-ents and doctors. www.organigram.ca 3

  4. Slide 4: Investment Highlights

    INVESTMENT HIGHLIGHTS 1 of only 13 Licensed Producers in Canada First and only Licensed Producer east of Ontario – Fully bilingual branding and services 500% Produc-on Growth by January 2015 Highest Quality, Organic, Condi-on Specific Marijuana Grown in Canada Experienced and proven senior management

  5. Slide 5: Customers, Ordering, Quantity, Quality and Pricing

    CUSTOMERS: Customers are medical marijuana pa-ents in Canada ORDERING: Prescrip-on order process – factory direct QUANTITY: Product is sold by the gram Every product is independently QUALITY: tested with full transparency for pa-ents and doctors PRICING: Pricing is per gram. Using $6 -­‐ $9/gram in

  6. Slide 6: Location

    LOCATION First and only Licensed Producer east of Ontario www.organigram.ca 6

  7. Slide 7: Unique Technology & Intellectual Property Platform

    UNIQUE TECHNOLOGY & INTELLECTUAL PROPERTY PLATFORM OrganiGram Inc. OrganiGram Inc. American Cannabis Company Inc. MulL-­‐Level Setup Exclusive Canada – US Partnership Cube Technology Bio Track True Living Stackable Organics Enclosed Seed to sale tracking system Tightly controlled environment www.org

  8. Slide 8: True Living Organics

    TRUE LIVING ORGANICS What is True Living Organics (TLO)? • TLO is the science of managed micro life enriched soil • 100 % Organic – specifically amended soil (coco coir) with 15 + natural and biologically posi-ve addi-ves – Perfec-ng Nature’s Profile What are the benefits of using True Living Organics

  9. Slide 9: Condition-Specific Medical Marijuana

    CONDITION-SPECIFIC MEDICAL MARIJUANA BRAND/ # OF CATAGORY CONDITION PRICE/GM* AVAILABLE STRAINS HIV/AIDS, Cancer, Anorexia, ORGANIGRAM ACN Chemotherapy & Radiation $7-9 Q4 4 STIMULATE APPETITE, CONTROL NAUSEAU Patients ORGANIGRAM ANXIETY AND STRESS DISORDERS ASD Anxiety & PTSD $7-9 Q4 4 Compassionat

  10. Slide 10: Customer Intake Process

    CUSTOMER INTAKE PROCESS www.organigram.ca 10

  11. Slide 11: Patient Acquisition Approach

    PATIENT ACQUISITION APPROACH Established and Growing Sales Team • Strategic TargeLng of Key Health Care Professional (HCP) Stakeholders in the areas of Pain / SpasLc / Psychological Disorders • Sales Team for NS, NB, PEI, and QC (as of Aug 11th) – each with minimum of 10 years of PharmaceuLcal Exper

  12. Slide 12: Exterior of Facility

    EXTERIOR OF FACILITY www.organigram.ca 12

  13. Slide 13: Facility Expansion Approach

    FACILITY EXPANSION APPROACH First expansion amendment to MMPR Applica-on has been approved (Through Phase 3) www.organigram.ca 13

  14. Slide 14: Financial Forecast

    FINANCIAL FORECAST Year 2015 2016 2017 2018 Patients 2,800 7,400 11,300 16,500 Production (KG) 1,500 4,000 6,200 9,000 Revenue $10.7M $28.3M $43.3M $63.2M Pre Tax Profit $3.1M $13.5M $22.2M $33M www.organigram.ca 14

  15. Slide 15: Capitalization Table

    CAPITALIZATION TABLE Issued and Outstanding 51,559,332 Warrants Nil Op-ons Nil Fully Diluted 51,559,332 Cash ~$5.5M TSX Venture OGI OTCQB OGRMF *As of Oct 01, 2014 www.organigram.ca 15

  16. Slide 16: Future Opportunities

    FUTURE OPPORTUNITIES: Expansion Our license is a Federal property – provided we can demonstrate loca-on and staff security, we are allowed to expand our opera-ons anywhere in Canada All three major poli-cal par-es in Canada support commercializa-on of the marijuana industry at some level Merger & Acq

  17. Slide 17: Appendix

    APPENDIX www.organigram.ca 17

  18. Slide 18: Management

    MANAGEMENT Denis Arsenault – Director & CEO Amer gradua-ng from the University of Moncton in 1983 with a B.Comm, Denis spent just over a year working for Irving. Since 1985, Denis has build and sold 10 businesses in various industries and currently owns a poruolio of commercial and mul--­‐unit resid

  19. Slide 19: www.organigram.ca

    BreJ Allan-­‐ Director of Investor Rela-ons Mr. Allan brings 8 years of public markets and corporate finance experience to the Company. Mr. Allan is the President and CEO of Apex Capital Corp., which has provided capital markets and investor rela-ons services to a number of public companies since 201

  20. Slide 20: Board of Directors

    BOARD OF DIRECTORS Denis Arsenault – Director & CEO Roger Rogers – Director Larry Rogers – Director Mr. Rogers is the CEO and co-­‐founder of CLS Lexi-­‐tech Ltd., Canada’s largest private language service provider. He began his career in the informa-on technology field, before going on to play a key

  21. Slide 21: Contacts

    CONTACTS Corporate Head Office Investor Rela-ons OrganiGram, Inc. BreJ Allan, Director of Investor Rela-ons 35A English Dr. Suite 901 -­‐ 600 Queens Quay West Moncton, NB Toronto, ON E1E 3X3 M5V 3M3 info@organigram.ca breJ@organigram.ca Toll Free: 1-­‐855-­‐961-­‐9420 Toll Free: 1-­‐855-­‐888-­‐8123 L

OrganiGram — Investor Presentation (November 2014) on 6ix